Home > Insider Trading > Filing (0001289340-15-000061)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1289340	Stereotaxis Inc.	STXS	Electromedical & Electrotherapeutic Apparatus (3845)	943120386

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1267959	A Fred Middleton	C/O Stereotaxis, Inc. 4320 Forest Park Avenue, Suite 100 St. Louis MO 63108		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-06-15	26,064	$1.57	1,107,189	No	4	S	Indirect	Sanderling Venture Partners VI Co-Investment Fund, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Sanderling Venture Partners VI Co-Investment Fund, L.P.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	46,810	Direct
Common Stock	40,673	Indirect	Sanderling Ventures Management VI
Common Stock	6,358	Indirect	Sanderling VI Limited Partnership
Common Stock	5,335	Indirect	Sanderling VI Beteiligungs GmbH & Co. KG
Common Stock	1,500	Indirect	Sanderling Mgmt. LLC 401K Pension Profit Sharing Plan
Common Stock	53,275	Indirect	Sanderling IV Biomedical Co-Investment Fund, L.P.
Common Stock	11,097	Indirect	Sanderling V Beteiligungs GmbH & Co. KG
Common Stock	39,716	Indirect	Sanderling V Biomedical Co-Investment Fund, L.P.
Common Stock	11,956	Indirect	Sanderling V Limited Partnership
Common Stock	67,790	Indirect	Sanderling Venture Partners V Co-Investment Fund, L.P.
Common Stock	22,451	Indirect	Sanderling Venture Partners IV Co-Investment Fund
Common Stock	82	Indirect	Sanderling Ventures Management V

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $1.55 to $1.60, inclusive. The reporting person undertakes to provide Stereotaxis, Inc., any security holders of Stereotaxis, Inc., or the staff of the Securities and Exchange Commission, upon request, all information regarding the number of shares purchased at each separate price within the range set forth in this footnote.